Trudy Day
Nurse Practitioner · Petoskey, MINPI 1265590814
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,215 of the $9,585 with a category attached, or 85.7%. It is spread thinly across 31 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 519 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$1K
- Inspire Medical Systems, Inc.$919
- Regeneron Healthcare Solutions, Inc.$642
- Boehringer Ingelheim$641
- Jazz Pharmaceuticals Inc.$630
- plus $3K from 25 others
What the payments were for
- Consulting fees$3003%
- Travel & lodging$6617%
- Food & beverage$8,21586%
- Education$4094%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 92 | $1,874 |
| GSK | 144 | $1,404 |
| Inspire Medical Systems, Inc. | 7 | $919 |
| Regeneron Healthcare Solutions, Inc. | 33 | $642 |
| Boehringer Ingelheim | 33 | $641 |
| Jazz Pharmaceuticals Inc. | 22 | $630 |
| Mylan Specialty L.p. | 48 | $576 |
| Sanofi | 19 | $354 |
| Harmony Biosciences LLC | 12 | $336 |
| Insmed, Inc. | 10 | $318 |
| Grifols USA, LLC | 15 | $311 |
| Amgen | 15 | $257 |
| Actelion Pharmaceuticals US, Inc. | 12 | $251 |
| Verona Pharma, Inc. | 15 | $186 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $128 |
| Axsome Therapeutics, Inc. | 5 | $95 |
| Electromed, Inc. | 5 | $80 |
| Viatris Specialty LLC | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 4 | $56 |
| Lilly USA, LLC | 3 | $51 |
| Philips North America LLC | 3 | $44 |
| Eisai Inc. | 2 | $32 |
| Resmed Corp | 2 | $31 |
| United Therapeutics Corporation | 1 | $29 |
| Pulmonx Corporation | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Pfizer | 1 | $19 |
| ZOLL Respicardia, Inc. | 1 | $18 |
| Vifor Pharma, Inc. | 1 | $15 |
| La Jolla Pharmaceutical Company | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,585 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 521 | $531,780 |
| OfevNintedanib Esylate | 23 | $305,440 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 149 | $137,654 |
| Breo ElliptaFluticasone/Vilanterol | 133 | $87,741 |
| Dupixent SyringeDupilumab | 23 | $82,484 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 99 | $68,018 |
| Spiriva RespimatTiotropium Bromide | 63 | $50,041 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 206 | $38,354 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 39 | $28,209 |
| Spiriva HandihalerTiotropium Bromide | 40 | $25,728 |
| Incruse ElliptaUmeclidinium Bromide | 39 | $23,320 |
| SymbicortBudesonide/Formoterol Fumarate | 59 | $23,093 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 17 | $20,853 |
| Advair HfaFluticasone Propion/Salmeterol | 38 | $20,530 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 45 | $18,604 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $1,404 | $719,932817 claims |
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat, Combivent Respimat | $641 | $404,543142 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,874 | $160,747208 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $56 | $8,27020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Petoskey
- Martha GoetzPetoskey$101K
- Joshua MartinPetoskey$31K
- Davida KrugerDetroit$739K
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Lisa Astalos ChismWoodhaven$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.